Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BEAUTY AND THE BEAST - TATTOO OG BEAUTY CLINIC, HOLSTEBRO ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   12.8% 6.4% 14.5% 7.5% 9.2% 39.4% 20.6% 20.4%   Credit score (0-100)   21 39 16 34 27 0 4 4   Credit rating   BB BBB BB BB BB C B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,412 1,983 1,845 2,706 4,036 2,226 0.0 0.0   EBITDA   106 200 304 260 55.0 -775 0.0 0.0   EBIT   101 196 304 260 55.0 -775 0.0 0.0   Pre-tax profit (PTP)   96.2 197.3 -150.3 265.9 48.0 -805.4 0.0 0.0   Net earnings   108.1 150.5 -221.1 165.3 -41.5 -805.4 0.0 0.0   Pre-tax profit without non-rec. items   96.2 197 -150 266 48.0 -805 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Tangible assets total   3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   -14.5 136 -85.2 80.2 38.6 -767 -817 -817   Interest-bearing liabilities   77.1 73.7 0.0 0.0 0.0 141 817 817   Balance sheet total (assets)   355 547 308 473 1,209 767 0.0 0.0   Net Debt   -121 -41.4 -43.3 -128 -73.1 114 817 817     See the entire balance sheet 1000.0 Volume  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,412 1,983 1,845 2,706 4,036 2,226 0.0 0.0   Gross profit growth   0.0% 40.5% -7.0% 46.7% 49.2% -44.9% -100.0% 0.0%   Employees   7 10 5 6 9 7 0 0   Employee growth %   0.0% 42.9% -50.0% 20.0% 50.0% -22.2% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   355 547 308 473 1,209 767 0 0   Balance sheet change%   0.0% 54.2% -43.7% 53.7% 155.4% -36.5% -100.0% 0.0%   Added value   100.5 196.1 304.1 260.5 55.0 -774.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -2 -7 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 -1.0 0.0 0.0   1000.0 Profitability  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   7.1% 9.9% 16.5% 9.6% 1.4% -34.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   27.2% 44.0% 68.6% 61.6% 7.0% -51.9% 0.0% 0.0%   ROI %   130.3% 140.6% 308.0% 665.4% 99.3% -717.4% 0.0% 0.0%   ROE %   30.5% 61.3% -99.6% 85.2% -69.9% -199.9% 0.0% 0.0%   1000.0 Solidity  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Equity ratio %   -3.9% 24.8% -21.7% 16.9% 5.8% -73.9% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -114.0% -20.7% -14.3% -49.2% -133.0% -14.8% 0.0% 0.0%   Gearing %   -532.0% 54.2% 0.0% 0.0% 0.0% -18.3% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   11.3% 5.8% 1,284.3% 0.0% 0.0% 133.4% 0.0% 0.0%   1000.0 Liquidity  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Quick Ratio   0.7 1.2 0.6 1.1 1.8 0.7 0.0 0.0   Current Ratio   0.8 1.2 0.7 1.1 1.0 0.5 0.0 0.0   Cash and cash equivalent   198.5 115.0 43.3 128.1 73.1 26.2 0.0 0.0   1000.0 Capital use efficiency  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -88.5 89.2 -131.9 33.5 -8.1 -761.4 -408.4 -408.4   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   14 20 61 43 6 -111 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   15 20 61 43 6 -111 0 0   EBIT / employee   14 20 61 43 6 -111 0 0   Net earnings / employee   15 15 -44 28 -5 -115 0 0